Skip to main content

Table 1 Comparison of clinical efficacy between two groups of patients (d, x ± s)

From: The effect of doxorubicin curcumin co-loaded lipid nanoparticles and doxorubicin on osteosarcoma before surgery

Group (n)

CR

PR

SD

PD

ORR

DCR

VAD group (34)

17 (50.00)

5 (14.71)

7 (20.59)

5 (14.71)

22 (64.71)

29 (85.29)

DOX + CUR LPNs group (34)

25 (73.53)

7 (20.59)

1 (2.94)

1 (2.94)

32 (94.12)

33 (97.06)

χ2

9.024

8.995

2.925

P

0.029

0.003

0.087